Ep. 109 - What's Next for Novartis? Plus: AACR, Merck KGaA
BioCentury This Week
00:00
ACR Conference - What's the Hot Trands at ACR?
The american association for cancer research annual meeting will run through wednesday the thirteenth. We've spent some time on cartea cells and solid humors that we talked about last week. At the conference was really positive data from fate therapeutics with induced floriboten stem cell derived an k cels. That sort of kicked off this movement of using this type of stem cells to immune cell therapies.
Transcript
Play full episode
